sdz 51641 has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, PA; Cohen, DK; Foley, JE; Ho, RS; McIntosh, RH; Nadelson, J; Young, DA | 1 |
1 other study(ies) available for sdz 51641 and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of hepatic glucose production by SDZ 51641.
Topics: Administration, Oral; Animals; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dioxolanes; Disease Models, Animal; Fatty Acids; Glucose; Hypoglycemic Agents; Ketones; Liver; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Triglycerides | 1990 |